BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Peterson LR, Schechtman KB, Ewald GA, Geltman EM, Meyer T, Krekeler P, Rogers JG. The effect of β-adrenergic blockers on the prognostic value of peak exercise oxygen uptake in patients with heart failure. The Journal of Heart and Lung Transplantation 2003;22:70-7. [DOI: 10.1016/s1053-2498(02)00473-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Coggan AR, Broadstreet SR, Mahmood K, Mikhalkova D, Madigan M, Bole I, Park S, Leibowitz JL, Kadkhodayan A, Thomas DP, Thies D, Peterson LR. Dietary Nitrate Increases VO2peak and Performance but Does Not Alter Ventilation or Efficiency in Patients With Heart Failure With Reduced Ejection Fraction. J Card Fail 2018;24:65-73. [PMID: 28916479 DOI: 10.1016/j.cardfail.2017.09.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
2 Carvalho VO. Aerobic exercise prescription in patients with chronic heart failure: a review in the beta-blocker era. J Cardiovasc Med (Hagerstown) 2012;13:570-4. [PMID: 22828773 DOI: 10.2459/JCM.0b013e328356a3b2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 Buber J, Robertson HT. Cardiopulmonary exercise testing for heart failure: pathophysiology and predictive markers. Heart 2022:heartjnl-2021-319617. [PMID: 35410893 DOI: 10.1136/heartjnl-2021-319617] [Reference Citation Analysis]
4 Uithoven KE, Smith JR, Medina-Inojosa JR, Squires RW, Van Iterson EH, Olson TP. Clinical and Rehabilitative Predictors of Peak Oxygen Uptake Following Cardiac Transplantation. J Clin Med 2019;8:E119. [PMID: 30669449 DOI: 10.3390/jcm8010119] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
5 Wolfel EE. Exercise testing with concurrent beta-blocker usage: is it useful? What do we learn? Curr Heart Fail Rep 2006;3:81-8. [PMID: 16928341 DOI: 10.1007/s11897-006-0006-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
6 Yancy CW. Practical considerations for BNP use. Heart Fail Rev 2003;8:369-73. [PMID: 14574060 DOI: 10.1023/a:1026107701983] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
7 Adams KF Jr. Are angiotensin-converting enzyme inhibitors and beta-blockers making an impact on the epidemiology of heart failure? Curr Cardiol Rep 2004;6:162-8. [PMID: 15075049 DOI: 10.1007/s11886-004-0018-7] [Reference Citation Analysis]
8 Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Journal of the American College of Cardiology 2022. [DOI: 10.1016/j.jacc.2021.12.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]